It's simple, imo trust and credibility remain the big
It's simple, imo trust and credibility remain the big issues for support. Joe's vision/business plan , missed targets and funding/lawsuits increase the risk for any institution to participate. Investing in Management and potential has turned into SHOW ME ......the result is lack of funding, lawsuits and ongoing dilution. If the transition of IP has started the China deal will turn quiet and potential revenues questionable............in addition other investors may not see the big value for future research. Big pharma doesn't wait around for NGIO .......they will provide boosters if necessary. ......no big deal for people to stop by CVS, Walgreens etc to get another shot......5 min, and supplies will be a non issue in 6-12 months.
No info on core business or revenue and the blah blah blah goes on and on. Joe had his chance and should resign unless his ego can't handle it.....the BOD needs to step up.
Since late 2018 we have been talking about Nasdaq ........HIGH PRIORITY !! Due-diligence answers any questions, as far as "World Class Management " .......you decide. The Scientific Board may have qualified people but they don't decide on the direction of the company. We need a seasoned reputable leader to restore trust/credibility and results. A little success won't erase the past ..........
Don't expect a huge IPO if Dawson James is still on board, and what is the plan when funds become available.......dump it in the "business plan" ....run out and start dilution allover .......it will take time to generate revenue .........
Altucell still around? Without any transparency and truthful updates any assumptions is valid until proven inaccurate!!
4
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...
Continue Reading
Hyundai's October Sales Soar to Record Heights Who would've thought that a company known for its affordable sedans would swipe October's sales crown? That's exactly what Hyundai did this past month, stirring up the automotive market with record-breaking figures. Their total sales for October clocked in at a whopping 73,452 units—a solid 5% hike compared to last year....
Continue Reading
A Major Milestone for Precision Medicine Ultima Genomics just nabbed a big one, folks. They're going front and center with Singapore's National Precision Medicine (NPM) Program for Phase III, marking no small feat in the ambitious world of genomics. This is more than just another feather in their cap—it's a power move in the cutthroat race for sequencing supremacy. And...
Continue Reading
A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...
Continue Reading
Union Rumble: Parking Showdown in Chicago In the windy streets of Chicago, nearly 1,200 members of Teamsters Local 727 are striking, and folks, it's not just about parking cars. These workers have thrown down the gauntlet against parking operators throughout Chicagoland. They're not just peeved with a bad offer—they're downright firing back at labor law violations,...
Continue Reading
Corporate Deals Under the Microscope: What's at Stake? The headlines are shouting: ADT, Instacart, and Ultralife are all embroiled in merger activities that might not exactly be what shareholders signed up for. On the surface, you've got big names like DoorDash stepping up to snag some of these firms, but the question here is whether the deals are truly fair—or if...
Continue Reading
An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...
Continue Reading
Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...
Continue Reading
Revving Up the Engines in the Orinoco Belt And HERE we are again, ringing the bell on another bold move in the world of energy. NABEP is pulling back the curtain on their revamped activities in the Orinoco Belt. You're telling me they just fired up one heck of a furnace? In this relentless pursuit to spike their output, you've gotta respect the hustle. It's like cranking...
Continue Reading
Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...
Continue Reading
Top 5 Most Recently Viewed Articles
TransUnion Set to Announce Third Quarter Earnings TransUnion (NYSE: TRU) is preparing to share its financial results for the third quarter. This announcement will come through a press release set for October 23. Investors and other interested individuals can anticipate this crucial update to be released around 6:00 a.m. Central Time (CT). Details of the Conference Call...
Continue Reading
Bitnomial Achieves CFTC Approval to Launch Innovative Prediction Markets Bitnomial, Inc., a prominent U.S. derivatives exchange, has reached an exciting milestone in the world of finance. The Bitnomial Clearinghouse, LLC has successfully received approval from the Commodity Futures Trading Commission (CFTC) to offer fully-collateralized swaps, paving the way for the...
Continue Reading
TEN Ltd. Announces Significant Dividend on Preferred Shares TEN Ltd. is proud to announce that its Board of Directors has declared a regular quarterly cash dividend of approximately $0.59375 per share for its Series F Cumulative Redeemable Perpetual Preferred Shares. This announcement showcases the company’s commitment to delivering value to its shareholders. Details on...
Continue Reading
Payment systems have evolved dramatically over centuries, transforming from simple barter exchanges to complex digital networks that facilitate instant global transactions. As financial technology continues to advance, investors must stay informed about these changes to identify emerging opportunities and navigate potential risks. Understanding how payment systems have...
Continue Reading
Yellowstone Bourbon’s Commitment to National Park Preservation Yellowstone Bourbon has made a significant impact in the realm of environmental conservation by donating a remarkable total of $1 million to the National Parks Conservation Association (NPCA). This achievement reflects Yellowstone Bourbon’s dedication to preserving and protecting our cherished natural...
Continue Reading